chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lip swelling; eye lid swelling; she couldn't wake up from bed, she couldn't move her feet; Face swelling,; Can't pick up feet; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (Face swelling,), GAIT DISTURBANCE (Can't pick up feet), LIP SWELLING (lip swelling), SWELLING OF EYELID (eye lid swelling) and FATIGUE (she couldn't wake up from bed, she couldn't move her feet) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was provided by the reporter.  Concomitant products included ATORVASTATIN CALCIUM (LIPTOR [ATORVASTATIN CALCIUM]) and HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL/HYDROCHLOROTHIAZIDE) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced SWELLING FACE (Face swelling,) and GAIT DISTURBANCE (Can't pick up feet). On an unknown date, the patient experienced LIP SWELLING (lip swelling), SWELLING OF EYELID (eye lid swelling) and FATIGUE (she couldn't wake up from bed, she couldn't move her feet). At the time of the report, SWELLING FACE (Face swelling,), GAIT DISTURBANCE (Can't pick up feet), LIP SWELLING (lip swelling), SWELLING OF EYELID (eye lid swelling) and FATIGUE (she couldn't wake up from bed, she couldn't move her feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
temp over 101; severe headache;  body aches; neck ache; extreme fatigue; beginning approximately 11PM on 3/16/21, worsened as the day progressed; loss of appetite
No adverse effects; a patient was administered the second dose of VAQTA too soon; This spontaneous report as received from a registered nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 02-JAN-2019, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) first dose, intramuscularly (lot#, expiry date and anatomical location was not reported) for prophylaxis. On 19-APR-2019, the patient was vaccinated with the second dose of hepatitis a vaccine, inactivated (VAQTA) lot# R031045, expiry date: 18-NOV-2019, which was reported as too soon after the first dose, and was considered as an inappropriate schedule of product administration.  The outcome of the event was unknown.
~10:AM  2/09/21 onset of detectable light headedness - progressed stronger to 7:30PM, but still remained functional, and reduced with food.  3:30PM - 2/9/21 Taking easy chair nap - awoke with right hand numb up to elbow, but still had feeling and could move.  10 min of moving dissipated the numbness completely.  5:30PM - 2/9/21 - Drove car for 25 min, after 15 min left foot began numbing, by arrival tingling to upper thigh, but after walking for ~10min completely dissipated.  No other symptoms other than soreness at the injection site, mild like a sensitive bruise.
Patient received vaccine in the office on 6/2/14 around 10:30am, patient called the office on 6/3/14 at 1:36pm stating that she was having fevers of 102.0 degrees, arm and neck pain.
DTAP-IPV liquid portion of the vaccine was already administered to the patient without mixing the Hib part with no reported adverse event; Initial information received on 29-Mar-2022 regarding an unsolicited valid non-serious case received by other health professional.  This case involves an 8 week old female patient to whom DTAP-IPV liquid portion of the vaccine was already administered without mixing the HIB part with no reported adverse event while receiving vaccine Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine [Pentacel].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Pneumococcal Vaccine Conj 7V (CRM197) (Prevnar) for Prophylactic vaccination.  On 28-Mar-2022, the patient received Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine (form, strength: unknown; lot UJ593AAA) via intramuscular route in unknown administration site as Immunization.  On 28-Mar-2022 (latency: same day), the patient DTAP-IPV liquid portion of the vaccine was already administered to the patient without mixing the HIB part with no reported adverse event (product preparation issue).  Action taken: Not applicable.  Event outcome: Unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient claimed to get bursitis at injection site and required draining. Patient now needs 6 weeks of physical therapy.
About 12 hours post-vaccine, I began feeling ill with chills and night sweats (but no temperature). After a night of fitful sleeping, I awoke the next morning feeling under the weather. I took Tylenol early that morning (around 8 a.m.). Subsequently, I took a nap at 10:45 a.m. and awoke around 3:30 p.m. with a very high temperature of 103.9. I took Tylenol immediately and my temperature rose to 104.2 (measured by head-scanning thermometer) within 15-30 minutes. I was dizzy, nauseated, almost unable to walk or sit up straight, and frankly was the sickest I have ever been in my life. I took a cold shower sitting down and within an hour my temperature had dropped to 101. I slowly began to feel better over the next 2-3 days, with symptoms lessening quickly that evening. I would absolutely take the vaccine over again, but wish that I had been advised that a very high temperature could occur in a very small subset of people. All the literature from the vaccine site and other government institutions did not note the possibility of a temperature of 103 - 104 degrees.
This spontaneous report was received from a nurse practitioner via field representative and refers to a female patient of unknown age, who was not in a pregnant. On an unknown date the patient was vaccinated with first, second and third dose of GARDASIL ( intramuscular, 0.5 ml, after 0, 2 and 6 months respectively). On an unknown date the patient experienced a positive pap smear that demonstrated oncogenic hpv type (unspecified number). Pap smear was performed with positive result. The patient sought medical attention and no treatment was given. The physician informed the field representative that the patient was due for her third GARDASIL injection. Physician also informed the field representative that she was uncertain as to providing the third injection. The outcome of a positive pap smear that demonstrated oncogenic hpv type was not reported. The relatedness between GARDASIL and positive pap smear that demonstrated oncogenic hpv type was not reported. It was reported that the therapy with GARDASIL was continued. Additional information has been requested.
Rash developed on upper thighs, chin, neck & postauricular areas - not pruritic.
Caught Covid-19 on Sept 30, 2021. Extremely ill for 3-4 weeks. Chronic cough, fatigue ,nausea, brain fog,  loss of smell & taste, extreme tiredness.  Have long term lasting effects: brain fog, hair loss, numbness in finger tips after antibodies infusion, fatigue, aches in ligaments and joints, continued breathing issues.
Patient had fever peaking at 104.5, full body sweats (when no fever was present), exhaustion, light headed/dizziness, micro-blackouts, joint pain, muscle pain, migraines, lacked focus/concentration, and was easily winded while doing every day tasks. Symptoms lasted for 5 days.
Within 30-45 minutes my arm began to hurt and the pain intensified throughout the day to the point that I could barely lift my arm. Around 3-4PM I started to have some headache which was light at first but got worse as the evening went on, I finally had to give in and take tylenol around 9PM.  I also started to get tired into the evening. The following  day I continues to have a headache, arm pain, some neck/upper back pain, fatigue. I slowly improved throughout the day day to the point that I barely had a headache or pain by the time I went to bed. I woke up feeling much better the next day. I also was very congested and sneezing a lot starting the day following the vaccine throughout the second day after it, I think this was related to weather changes.
9 hours after injection, I began having uncontrollable chills followed by extreme aching in my muscles, sever headache, and nausea. In other words, symptoms of the flu itself. As I am writing this on October22nd, I still feel week and unwell.
This case was reported by a nurse via sales rep and described the occurrence of injection site pain in a 18-year-old female patient who received BEXSERO. On an unknown date, the patient received the 1st dose of BEXSERO. On an unknown date, 1 day after receiving BEXSERO, the patient experienced injection site pain and injected limb mobility decreased. On an unknown date, the outcome of the injection site pain and injected limb mobility decreased were unknown. It was unknown if the reporter considered the injection site pain and injected limb mobility decreased to be related to BEXSERO. Additional details were provided as follows: The reporter stated that, 24 hours after administration of BEXSERO, the patient experienced severe pain at the injection site and the patient had trouble in lifting her arm where he got the injection. The reporter did not have any further information. This case has been linked with US2016GSK070376 reported by same reporter.
Information has been received from a physician assistant referring to a female patient of unknown age. Patient's relevant medical history, concurrent conditions and drug reactions/allergies were unspecified. She was not pregnant. On 12-OCT-2009 the patient was vaccinated with second dose of (Oka/Merck) VARIVAX subcutaneous (strength, dose, frequency, lot # , expiry date not reported) (inappropriate schedule of drug administration). Patient received her first dose of (Oka/Merck) VARIVAX on 17-MAR-1998. No concomitant medications were reported. Reporting physician assistant stated that patient had low titers for (Oka/Merck) VARIVAX (antibody test negative). Patient did not required medical attention. No treatment was provided for the adverse event). Outcome                                                 of the event, antibody test negative was unknown. Reporting physician assistant did not assessed the causality  of the event with respect to vaccination with (Oka/Merck) VARIVAX. Additional information has been requested.
Patient was given vaccine with wrong diluent; mother contacted and brought patient in for revaccination on 7/11/2017.
About 1hr after administration of vaccination patient had onset of urticaria 1 degree on arm (upper) and upper legs-led to hives-same area-symptoms lessened by evening.  Awoke next morning with facial swelling.  No dyspnea or difficulty swallowing  Treatment with Medrol dose pack, Zyrtec.
Onset 5 days after vaccination of midsternal chest pain worse with lying down and eating, better with hunching forward. Symptoms lasted 3 dyas.
Patient received expired vaccine. Expired 3/26, received 3/30. No adverse effects. Patient opted to not be revaccinated.
I received the first dose on the 16th that night I had soreness to the arm and didn't feel good just general body mild aches. Next day I felt better the following night I felt like I had some mild flu again next day I was better and then I seem to return to normal on the evening of the 23rd I started to feel like I have a little bit of a fever or headache but I didn't register a fever on the 24th I felt like I had a mild cold that evening it got worse my headache was getting much worse my head hurt a lot but there was no temperature the 25th I didn't feel good so I went ahead and went down and took a code test then the 26 I was feeling a lot worse I had had been in the bathroom all day no diarrhea just constantly having to clear my bowels I had a bad headache sore throat dry mouth just felt bad so I went and got a wrap it cuz it test it came back negative on the 27th which is today I got the results from the regular test I took on the 25th and it was negative I still don't feel good I'm very fatigued my head hurts I overall just don't feel good my throat hurts so I'm not sure if I just caught a regular flu or what's going on I pretty much self isolate I've been to the hospital to get my shot on the 16th I went to the doctor's office for a routine Pap test on the 19th and I went to grocery store one time. I did go into a fishing store on 23rd to get a net I was only in the store for 5 minutes and I double mask. Today once again I have no energy my head hurts it's not the headache isn't is bad I just feel like there's something wrong with my head my throat still hurts my mouth is still a little dry so I'm not sure if this is just a flu but I wanted to report the symptoms just in case
Got my first vaccine of Moderna on the 4th of May and got the second shot on the 16th of June; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got my first vaccine of Moderna on the 4th of May and got the second shot on the 16th of June) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got my first vaccine of Moderna on the 4th of May and got the second shot on the 16th of June). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got my first vaccine of Moderna on the 4th of May and got the second shot on the 16th of June) had resolved.            No concomitant medication were reported by the reporter. Treatment medication was not reported by the reporter.
Day 2 the spotting got heavier; Mid-cycle menstrual bleeding (starting 6 hours after receiving the vaccine); This is a spontaneous report from a non-contactable healthcare professional, the patient. A 25-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03Sep2021 at 16:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 03Sep2021 at 22:30, 6 hours after the vaccination, the patient experienced mid-cycle menstrual bleeding. On 04Sep2021, day 2, the spotting got heavier. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mid-cycle menstrual bleeding and day 2, the spotting got heavier was resolving at the time of this report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Lt deltoid a size of an egg. Swelling warm on the area. Some pain. Mom gave pt Benadryl, Motrin and hydrocortisone cream was applied. By the day after reaction was mostly cleared.
An hour after the vaccination, his legs felt heavy above his ankles. He also had blurred vision. His mother called the doctor and they told her to monitor him. Go to ER/urgent care if things got worse.
Patient presents for swelling and redness around vaccine site on left arm. The swelling began the night after the vaccination on 12/17/2015, became worse and associated with low grade fevers and chills per patient that lasted 48 hours. No swelling of lips or tongue, no breathing difficulty. She followed up on 12/21/2015 and showed me the site, which was red from shoulder to elbow. Did no appear infected and patient reassured that it was a localized allergic reaction. Again, no signs of anaphylaxis. Patient presents again today, this time specifically for this pain and swelling. It is "profoundly different". The swelling is now just around the injection site, it is painful and there is now an area of discoloration. No fever, no difficulty breathing.
Headache, Myalgia, Fever,  injection site soreness, Left lymph nodes swollen, back pain  Narrative:
Diarrhea that have gotten progressively worse; Felt crappy, in bed all day; Achy; Headache; Redness in arm of injection; Tenderness in arm of injection; A spontaneous report was received from a consumer concerning a 76-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events diarrhea that have gotten progressively worse, achy/ pain, headache, felt crappy, in bed all day/ malaise, redness in arm of injection/ vaccination site erythema, tenderness in arm of injection/ vaccination site pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Feb 2021, prior to the onset of the events the patient received their dose of mRNA-1273 (lot/batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events diarrhea that have gotten progressively worse, achy, headache, felt crappy, in bed all day, redness in arm of injection, tenderness in arm of injection.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, diarrhea that have gotten progressively worse, achy, headache, felt crappy, in bed all day, redness in arm of injection, tenderness in arm of injection was unknown.
pt recv vax 4NOV95 & 5NOV95 pt devel swollen glands in ax area in addition to an inj site rxn characterized by redness, tenderness & swelling;pt had not yet recovered as of the reporting date;
Patient developed pain in the arm a few hours after the injection.  Pain significantly worsened over the rest of the day to the point that she could not move the arm for 2-3 days.  Symptoms then improved for a few days, but have worsened again in the last 48 hours.  No swelling or erythema.
Patient came in pharmacy and requested to get Shingrix and flu vaccine. After vaccines consent was filled out and vaccines processed. Pharmacist asked patient is this your first dose of Shingrix vaccine, he replied yes. All vaccines were give to patient. 5 minutes later, patient came back to pharmacy and asked: Do he need Shingrix vaccine every year? Pharmacist replied NO, only 2 doses series. He said he already got 2 doses of Shingrix last year. Insurance did not reject while processing 3rd dose of Shingrix. No reaction occurred at this point.
This spontaneous report as received from a registered nurse refers to a male patient of unknown age. On an unknown date, the patient was vaccinated with an unspecified number of doses of GARDASIL or GARDASIL 9 (dose, route and site of administration were not reported for both). On an unknown date, the patient was diagnosed with an unspecified cancer. The patient sought medical attention for diagnosis of cancer and an unspecified type of cancer treatment. The outcome of cancer was unknown. The relatedness between the event and GARDASIL or GARDASIL 9 was not reported. Upon internal review the event of unspecified cancer was considered to be medically significant. Additional information has been requested.
Pain in left arm,  extreme red chest, neck, and face.  Swelling of neck and face with heat.  Skin has been peeling, tight and dried out.
numbness of half left face; numbness of tongue; headache; pain on left arm; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 31Mar2021 at 12:00(at the age of 48-year-old), as a single dose for COVID-19 immunisation. Medical history included gout and high cholesterol. Concomitant medications included pyridoxine hydrochloride, biotin, folic acid, cholecalciferol, cyanocobalamin, phytomenadione, nicotinamide, sodium ascorbate, calcium pantothenate, thiamine mononitrate, zinc oxide, potassium iodide, manganese sulfate, chromic chloride, dl-alpha tocopherol acetate, sodium selenate, sodium molybdate dihydrate (CENTRUM VITAMINTS). No known allergies were reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 12:30 the patient experienced numbness of tongue, headache, pain on left arm and numbness of half left face. Therapeutic measures were taken as a result of adverse events and included treatment with TYLENOL 500 MG. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events numbness of half left face, numbness of tongue, headache, pain on left arm were unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Day 1, 3/29:  got the 1st dose of Pfizer Covid vaccine  (left arm) Day 2-- Day 8: 3/30-- 4/5: Couldn't lift my left arm (where the vaccine was given) for the whole day of 3/30.  Felt pain/sore of my left arm, but gradually got better and better.  Day 5: 4/2: noticed a penny size bruise on my left index finger,  close to my palm. No pain and I didn't find any other bruise in my body. The bruise lasted for 4-5 days.
covid vaccine breakthrough case  dose 1 Moderna  4/23/21  007C21A dose 2 Moderna  5/22/21  041C21A dose 3 Moderna  1/6/22  059H21A
Patient received 0.25ml dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INCORRECT DOSE ADMINISTERED (Patient received 0.25ml dose) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 25-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Patient received 0.25ml dose). At the time of the report, INCORRECT DOSE ADMINISTERED (Patient received 0.25ml dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details for events was not provided.   This report refers to a case of incorrect dose administered for mRNA-1273, lot # 017B21A with no associated AEs.   Reporter did not allow further contact